POST Online Media Lite Edition


Biocure appoints Bjorn Cochlovius as president

Christian Fernsby |
Vancouver, BC, Canada - Biocure, a biotech company, appointed Bjorn Cochlovius as president.

Article continues below

Dr. Cochlovius is a Molecular Biologist and Associate Professor for Immunology at Heidelberg University, Heidelberg, Germany.

Dr. Cochlovius' academic career focused on Tumor Immunology and Recombinant Antibodies.

Dr. Cochlovius has been Guest Scientist at Zelig Eshhar's lab at the Weizmann Institute, a pioneer of CAR-T cell technology.

He then joins the industry and held various leadership positions in biotech (e.g. Affitech, Oslo) and big pharma (amongst others at Roche, Basel; Abbvie, Singapore) in R&D, BD&L and strategic positions.

 LATEST MOVES FROM British Columbia 

Holly Street Capital appoints Anthony Viele to board
Cielo Waste Solutions appoints Gregg Gegunde as COO
Northstar Clean Technologies appoints Aidan Mills as CEO
Fjordland Exploration appoints John Sheedy as director
ArcWest Exploration appoints two directors